List of Chronicled MediLedger Customers
Chronicled
121 Minna St,
San Francisco, 94105-3701, CA,
United States
San Francisco, 94105-3701, CA,
United States
1 415-355-4681
Retail
10
$1M
Since 2010, our global team of researchers has been studying Chronicled MediLedger customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased Chronicled MediLedger for Blockchain Platform from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using Chronicled MediLedger for Blockchain Platform include: McKesson, a United States based Distribution organisation with 45000 employees and revenues of $359.10 billion, Cencora, a United States based Life Sciences organisation with 46000 employees and revenues of $294.00 billion, Cardinal Health, a United States based Healthcare organisation with 53084 employees and revenues of $222.58 billion, Walgreens Boots Alliance, a United States based Retail organisation with 312000 employees and revenues of $147.70 billion, Johnson & Johnson, a United States based Life Sciences organisation with 138100 employees and revenues of $88.82 billion and many others.
Contact us if you need a completed and verified list of companies using Chronicled MediLedger, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the Blockchain software purchases.
The Chronicled MediLedger customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of Blockchain software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
AbbVie | Life Sciences | 55000 | $56.3B | United States | Chronicled | Chronicled MediLedger | Blockchain Platform | 2017 | n/a |
In 2017 AbbVie joined a pilot of Chronicled MediLedger, a Blockchain Platform aimed at addressing pharmaceutical serialization and supply chain traceability requirements under the Drug Supply Chain Security Act. The pilot operated as a closed consortium with other pharmaceutical participants to vet members and focus on serialisation, track and trace, and supply chain integrity, positioning AbbVie to evaluate decentralized, tamper-resistant record keeping for drug provenance.
Chronicled MediLedger implements track and trace functionality, manufacturer-commissioned serial number issuance, and saleable returns workflows to record chain of custody. The MediLedger architecture stores cryptographically signed and encrypted entries across multiple nodes and leverages zero-knowledge proofs to enable regulatory compliance without requiring parties to share underlying transactional data. Functional capabilities described in the implementation include product serialisation, provenance tracking, cryptographic signing, and encrypted ledger persistence.
Operationally the MediLedger Blockchain Platform is framed as a closed network for vetted manufacturers, distributors, and other supply chain actors, with data persisted on separate nodes to reduce the risk of unilateral data manipulation. The implementation scope centers on supply chain and regulatory compliance functions, including serialization workflows and anti-counterfeiting verification rather than patient clinical records. The ledger topology supports peer-to-peer validation and shared provenance while limiting direct data exposure between trading partners.
Governance in the AbbVie pilot emphasized manufacturer authority to commission serial numbers and consortium-level rules for node participation, aligning process controls with cryptographic immutability and zero-knowledge proof patterns. Reported benefits from the pilot include improved resistance to hacking, enhanced ability to verify product authenticity, and clearer capability to pinpoint origins of suspected counterfeit activity. AbbVie deployed Chronicled MediLedger as a Blockchain Platform to support supply chain serialization and anti-counterfeiting business functions and to evaluate consortium governance for broader pharmaceutical traceability.
|
 |
Amgen | Life Sciences | 28000 | $33.4B | United States | Chronicled | Chronicled MediLedger | Blockchain Platform | 2021 | n/a |
In 2021, Amgen implemented Chronicled MediLedger, a Blockchain Platform, to participate in the MediLedger Network for enhanced pharmaceutical supply chain traceability and contract governance. The deployment positioned Amgen as an active network member alongside major U.S. wholesalers and manufacturers including AmerisourceBergen, McKesson, Cardinal Health, Genentech, Pfizer, Bayer and Gilead.
Chronicled MediLedger was configured to provide package level tracing to address DSCSA requirements, a returns tracking capability to mitigate counterfeit risk on returned products, and contract and membership functionality to create a single source of truth for Group Purchasing Organization membership and changing contract terms. The platform’s functional footprint emphasized traceability, returns reconciliation, and contract lifecycle coordination across supply chain stakeholders.
Architecturally the MediLedger Network began as a permissioned implementation based on Ethereum and later signaled evolution toward interoperability through a relationship with Parity, reflecting a network approach to governance and cross-chain connectivity. Amgen’s implementation relied on network-level data sharing rather than point to point integrations, enabling wholesalers, GPOs and manufacturers to reference the same validated event and contract records.
Operational coverage for the implementation included supply chain operations, returns processing, contract administration and regulatory compliance workflows, with transactions and membership changes propagated across participating organizations. Governance shifted toward shared, network-based data stewardship, which reduced instances of data mismatch between manufacturers, wholesalers and GPOs and streamlined dispute and billing query resolution.
The implementation leveraged Chronicled MediLedger’s package tracing and contract modules to support DSCSA compliance and to reduce billing errors and queries through a unified source of truth. The MediLedger Network continues to expand members and functionality, reinforcing network governance and cross‑participant data consistency.
|
 |
AstraZeneca | Life Sciences | 94300 | $74.0B | United Kingdom | Chronicled | Chronicled MediLedger | Blockchain Platform | 2023 | n/a |
In 2023 AstraZeneca deployed Chronicled MediLedger, implementing the Chronicled MediLedger Blockchain Platform to improve integrity and transparency across the pharmaceutical drug supply chain. Chronicled MediLedger is presented as a permissioned blockchain network for life sciences transacting, providing decentralized ledger capabilities for product provenance and traceability.
The implementation emphasized distributed ledger transaction recording and shared provenance capabilities, configured to capture supply events and reconcile transactional records between trading partners. The deployment model uses participant operated network nodes and permissioned access controls, leveraging immutable transaction records and cryptographic audit trails consistent with a Blockchain Platform.
Operational scope extended to multi-enterprise supply chain participants, with source material citing organizations including Pfizer, Johnson & Johnson, Cardinal Health, and AmerisourceBergen as network participants, which signals a networked model of manufacturers and distributors. Functionally the implementation impacts supply chain operations, distribution and regulatory control functions within AstraZeneca by enabling cross-organizational transaction visibility and standardized recordkeeping.
Governance was organized around shared ledger governance and standardized transactional records to support interoperability among trading partners and to establish common transactional workflows. Source materials describe the MediLedger network as poised to revolutionize life sciences transacting and to enhance supply chain transparency and integrity.
|
 |
|
Healthcare | 6550 | $2.0B | United States | Chronicled | Chronicled MediLedger | Blockchain Platform | 2020 | n/a |
|
|
|
|
Healthcare | 53084 | $222.6B | United States | Chronicled | Chronicled MediLedger | Blockchain Platform | 2021 | n/a |
|
|
|
|
Life Sciences | 46000 | $294.0B | United States | Chronicled | Chronicled MediLedger | Blockchain Platform | 2022 | n/a |
|
|
|
|
Life Sciences | 50605 | $65.2B | United States | Chronicled | Chronicled MediLedger | Blockchain Platform | 2020 | n/a |
|
|
|
|
Life Sciences | 13539 | $27.0B | United States | Chronicled | Chronicled MediLedger | Blockchain Platform | 2021 | n/a |
|
|
|
|
Life Sciences | 17600 | $28.8B | United States | Chronicled | Chronicled MediLedger | Blockchain Platform | 2019 | n/a |
|
|
|
|
Life Sciences | 138100 | $88.8B | United States | Chronicled | Chronicled MediLedger | Blockchain Platform | 2023 | n/a |
|
Showing 1 to 10 of 16 entries
Buyer Intent: Companies Evaluating Chronicled MediLedger
ARTW Buyer Intent uncovers actionable customer signals, identifying software buyers actively evaluating Chronicled MediLedger. Gain ongoing access to real-time prospects and uncover hidden opportunities. Companies Actively Evaluating Chronicled MediLedger for Blockchain Platform include:
- Life Science Connect, a United States based Media organization with 92 Employees
- Martlenz Research, a India based Professional Services company with 150 Employees
- AbbVie, a United States based Life Sciences organization with 55000 Employees
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
|---|---|---|---|---|---|---|---|---|
| No data found | ||||||||
FAQ - APPS RUN THE WORLD Chronicled MediLedger Coverage
Chronicled MediLedger is a Blockchain Platform solution from Chronicled.
Companies worldwide use Chronicled MediLedger, from small firms to large enterprises across 21+ industries.
Organizations such as McKesson, Cencora, Cardinal Health, Walgreens Boots Alliance and Johnson & Johnson are recorded users of
Chronicled MediLedger for Blockchain Platform.
Companies using Chronicled MediLedger are most concentrated in Distribution, Life Sciences and Healthcare, with adoption spanning over 21 industries.
Companies using Chronicled MediLedger are most concentrated in United States, with adoption tracked across 195 countries worldwide. This global distribution highlights the popularity of Chronicled MediLedger across Americas, EMEA, and APAC.
Companies using Chronicled MediLedger range from small businesses with 0-100 employees - 0%, to mid-sized firms with 101-1,000 employees - 0%, large organizations with 1,001-10,000 employees - 12.5%, and global enterprises with 10,000+ employees - 87.5%.
Customers of Chronicled MediLedger include firms across all revenue levels — from $0-100M, to $101M-$1B, $1B-$10B, and $10B+ global corporations.
Contact APPS RUN THE WORLD to access the full verified Chronicled MediLedger customer database with detailed Firmographics such as industry, geography, revenue, and employee breakdowns as well as key decision makers in charge of Blockchain Platform.